Treatment of the carcinoid syndrome with a depot formulation of the somatostatin analogue lanreotide
- 31 December 1994
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (10) , 1590-1591
- https://doi.org/10.1016/0959-8049(94)90065-5
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Pharmacokinetics and efficacy of a long-acting formulation of the new somatostatin analog BIM 23014 in patients with acromegalyJournal of Clinical Endocrinology & Metabolism, 1993
- Somatostatin Analogue Phase I Trials in Neuroendocrine NeoplasmsActa Oncologica, 1993
- Gastroenteropancreatic Endocrine Tumours: Effect of Sandostatin® on Tumour GrowthDigestion, 1993